The National Cancer Database (NCDB) is a large data set of cancer patients treated in the United States. In recent decades, many papers have utilized this database to study disparities in cancer care and outcomes. In this review, we present the strengths and limitations of using the NCDB to study cancer disparities, which should be taken into account by researchers who use the NCDB in this setting.
BoffaDJRosenJEMallinK, et al.Using the national cancer database for outcomes research: a review. JAMA Oncol. 2017;3(12):1722-1728. doi:10.1001/jamaoncol.2016.6905
2.
PalisBEJanczewskiLMBrownerAE, et al.The National Cancer Database conforms to the standardized framework for registry and data quality. Ann Surg Oncol. 2024;31(9):5546-5559. doi:10.1245/s10434-024-15393-8
SukniamKKasbiAAAsharyMA, et al.Disparities in time to treatment for breast cancer. Anticancer Res. 2022;42(12):5813-5818. doi:10.21873/anticanres.16088
5.
WeinerABKeeterM-KManjunathAMeeksJJ. Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: an update from the National Cancer Data Base (2004–2013). Urol Oncol. 2018;36(5):e9-e17. doi:10.1016/j.urolonc.2017.12.015
MubarakFKowkabanyGPoppR, et al.Early stage breast cancer: does histologic subtype (ductal vs. lobular) impact 5 year overall survival?Cancers. 2024;16(8):1509. doi:10.3390/cancers16081509
8.
WangFShuXPalT, et al.Racial/ethnic disparities in mortality related to access to care for major cancers in the United States. Cancers. 2022;14(14):3390. doi:10.3390/cancers14143390
9.
JiXCastellinoSMMertensAC, et al.Association of Medicaid expansion with cancer stage and disparities in newly diagnosed young adults. J Natl Cancer Inst. 2021;113(12):1723-1732. doi:10.1093/jnci/djab105
10.
Hicks-CourantKKoEMMatsuoK, et al.Secondary databases in gynecologic cancer research. Int J Gynecol Cancer. 2024;34:1619-1629. doi:10.1136/ijgc-2024-005677
11.
SchroederMCGaoXLizarragaIKahlARCharltonME. The impact of Commission on Cancer accreditation status, hospital rurality and hospital size on quality measure performance rates. Ann Surg Oncol. 2022;29(4):2527-2536. doi:10.1245/s10434-021-11304-3
12.
AvilaSRobersonMLRajagopalPS. Oncologists must consider participant data when using large-scale cancer data sets. JCO Clin Cancer Inform. 2024;8(8):e2300245. doi:10.1200/cci.23.00245
13.
ModiPKWardKCFilsonCP. Characteristics of prostate cancer patients captured by facility-based versus geography-based cancer registries. Urol Oncol. 2023;41(7):e1-e7. doi:10.1016/j.urolonc.2023.04.011
14.
SatpathyYNamPMoldovanM, et al.Comparison of capture rates of the National Cancer Database across race and ethnicity. JAMA Netw Open. 2023;6(12):e2350237. doi:10.1001/jamanetworkopen.2023.50237
15.
ValenciaCIAsmarSHsuC-H, et al.Renal cell carcinoma health disparities in stage and mortality among American Indians/Alaska Natives and Hispanic Americans: comparison of National Cancer Database and Arizona Cancer Registry data. Cancers. 2021;13(5):990. doi:10.3390/cancers13050990
16.
GrothSSHabermannEBMassarwehNN. United States administrative databases and cancer registries for thoracic surgery health services research. Ann Thorac Surg. 2020;109(3):636-644. doi:10.1016/j.athoracsur.2019.08.067
17.
KumarAGussZDCourtneyPT, et al.Evaluation of the use of cancer registry data for comparative effectiveness research. JAMA Netw Open. 2020;3(7):e2011985. doi:10.1001/jamanetworkopen.2020.11985
18.
MerkowRPRademakerAWBilimoriaKY. Practical guide to surgical data sets: National Cancer Database (NCDB). JAMA Surg. 2018;153(9):850-851. doi:10.1001/jamasurg.2018.0492
19.
MartinANChanNWCheungDCFongZV. A guide to large data sets for population-based cancer research: strengths, limitations, and pitfalls. Cancer. 2024;130:3802-3814. doi:10.1002/cncr.35535
20.
TangSCLinKYZengYY. Caution needed for using data of readmission from National Cancer Database. Am Surg. 2022;88(6):1384. doi:10.1177/00031348221078976
21.
KamarajahSKNathanH. Strengths and limitations of registries in surgical oncology research. J Gastrointest Surg. 2021;25(11):2989-2996. doi:10.1007/s11605-021-05094-y
22.
YangDXKheraRMiccioJA, et al.Prevalence of missing data in the National Cancer Database and association with overall survival. JAMA Netw Open. 2021;4(3):e211793. doi:10.1001/jamanetworkopen.2021.1793
23.
PlichtaJKRushingCNLewisHC, et al.Implications of missing data on reported breast cancer mortality. Breast Cancer Res Treat. 2023;197(1):177-187. doi:10.1007/s10549-022-06764-4
